Articles by Norman W. Baylor - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Norman W. Baylor

Norman W. Baylor


Regulatory Issues: Pandemic Preparedness Pacing Up
August 2, 2007

Any endpoint considered appropriate to support approval, whether a surrogate or a clinical endpoint, must be supported by substantial evidence of effectiveness.

ADVERTISEMENT

ADVERTISEMENT

Click here